<DOC>
	<DOCNO>NCT01873378</DOCNO>
	<brief_summary>The primary outcome study ass GnRHa administration cold loop hysteroscopic myomectomy contribute accomplish treatment one surgical procedure . Moreover , investigate intraoperative influence pharmacologic therapy term distension liquid absorption duration procedure .</brief_summary>
	<brief_title>GnRH Agonist Pretreatment Hysteroscopic Myomectomy</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>submucous myoma diagnose vaginal ultrasonography confirm diagnostic hysteroscopy premenopausal status present past history cancer pregnancy presence associate multiple polyp presence &gt; 2 myoma associate nonhysteroscopic surgical procedure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Uterine myoma</keyword>
	<keyword>GnRHa</keyword>
	<keyword>Hysteroscopy</keyword>
	<keyword>Cold loop</keyword>
</DOC>